Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination - Top-Institutions - MDSpire

Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination

  • By

  • Bing Han

  • Ming-Yue Bao

  • Qing-Qing Sun

  • Rui-Ning Wang

  • Xin Deng

  • Kun Xing

  • Feng-Lin Yu

  • Yan Zhang

  • Yue-Bo Li

  • Xiu-Qing Li

  • Na-Nan Chai

  • Gai-Xin Ma

  • Ya-Na Yang

  • Meng-Yuan Tian

  • Qian Zhang

  • Xing Li

  • Yuan Zhang

  • January 6, 2025

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neuroscience
    • Neuroimmunology
    • Multiple Sclerosis Research

  • #2

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neuroscience
    • Neurodegeneration
    • Stem Cell Biology

  • #3

    Massachusetts General Hospital / Harvard Medical School
    Massachusetts General Hospital / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Neuroimmunology
    • Regenerative Medicine

  • #4

    University of Cambridge
    University of Cambridge

    Cambridge, UK

    Key Differentiators

    • Neuroscience
    • Neurobiology
    • Multiple Sclerosis

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Sweden

    Key Differentiators

    • Neuroscience
    • Neurodegeneration
    • Stem Cell Research

Original Source(s)

Nuclear receptor PPARγ targets GPNMB to promote oligodendrocyte development and remyelination

  • by Bing Han, Ming-Yue Bao, Qing-Qing Sun, Rui-Ning Wang, Xin Deng, Kun Xing, Feng-Lin Yu, Yan Zhang, Yue-Bo Li, Xiu-Qing Li, Na-Nan Chai, Gai-Xin Ma, Ya-Na Yang, Meng-Yuan Tian, Qian Zhang, Xing Li, Yuan Zhang

  • January 6, 2025

Related Content

CSF Proteomics Identifies New Biomarkers for Multiple Sclerosis

Large-cohort CSF proteomics from the Mann Lab identifies a 22-protein panel distinguishing MS from related diseases

  • March 11, 2026

  • 3 min
Associations of Serum Alpha-Linolenic Acid with Disability and Brain Volume in Multiple Sclerosis: A Concise Replication Study

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness